Close Menu

With a Little Lemon?

AquaBounty's genetically modified salmon may soon be on plates in US restaurants or university cafeterias, the Associated Press reports.

To develop its modified salmon, AquaBounty added genetic material from other fish into Atlantic salmon so that it would grow about twice as quickly as usual, reaching full size within 18 months, the AP says. It adds that the company says that because the fish grow more quickly, it's more efficient as less feed is needed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Stephen Hahn, the nominee to lead the US Food and Drug Administration, underwent a Senate confirmation hearing yesterday, the Washington Post reports.

The US Food and Drug Administration has approved an RNA interference drug to treat acute hepatic porphyria.

Gizmodo looks over the past decade of consumer DNA testing to find the field to be lacking.

In Nature this week: native RNA sequencing and analysis of a human poly(A) transcriptome, nanopore sequencing-based method to analyze short tandem repeat expansions, and more.